reading tendon threads from 2024 and half of it aged badly
reading tendon threads from 2024 and half of it aged badly — a position I have arrived at slowly and would like tested. Regulatory classification differs between jurisdictions and has changed in several of them recently. Any answer to a status question needs a place and a date attached. Paid for identity confirmation…
Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.
Reconstituted or powder, and how long has it been in solution?
Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.
Assumed regulatory status was static and it was not. Checked again this year and the answer had changed where I live.
Assumed regulatory status was static and it was not.
Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.
read the actual papers, they are more modest than the summaries
That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.
the tendon claims are the most repeated and the least evidenced